The clinical role of molecular genetics in soft tissue tumor pathology

Cancer and Metastasis Reviews

Volumn 16, Issue 1-2, 1997, Pages 207-227

  Busam, K J ^a   Fletcher, C D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cytogenetics; sarcoma; soft tissue; tumor suppressor genes

Indexed keywords

HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW; SOFT TISSUE TUMOR; TUMOR SUPPRESSOR GENE;

CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; DIAGNOSIS, DIFFERENTIAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MOLECULAR BIOLOGY; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; SARCOMA, EWING'S; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0030965707     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005721114555     Document Type: Review

References (138)

1. Fletcher JA, Kosakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, Pinkus GS, Morton CC, Corson JM: Diagnostic relevance of clonoal cytogenetic aberrations in malignant soft tissue tumors. N Engl J Med 324: 436-443, 1991
2. Fletcher JA, Cytogenetic Analysis of Soft Tissue Tumors. In: Enzinger FM, Weiss SW (eds) Soft Tissue Tumors, St. Louis, MO, 3rd edition: 105-130, 1995
3. Meltzer PS: Molecular Biology of Soft Tissue Tumors. In: Enzinger FM, Weiss SW (eds) Soft Tissue Tumors, Mosby, St. Louis, MO, 3rd edition: 89-104, 1995
4. Sandberg AA, Bridge JA: The cytogenetics of bone and soft tissue tumors. RG Landers Co, 1994
5. Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RSK: Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 144: 1121-1134, 1994
6. Ladanyi M: The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 4: 162-173, 1995
7. Caspersson T, Zech L, Johansson C: Differential banding of alkylating fluorochromes in human chromosomes. Exp Cell Res 60: 315-319, 1970
8. Seabright M: A rapid banding technique for human chromosomes. Lancet 2: 971-972, 1971
9. Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, Gray J: Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocation of chromosome 4. Proc Natl Acad Sci USA 85: 9138-9142, 1988
10. Xiao S, Renshaw A, Cibas ES, Hudson TJ, Fletcher JA: Novel fluorescence in situ hybridization approaches to solid tumors. Am J Pathol 147: 896-904, 1995
11. Southern E: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-517, 1975
12. Saiki RK, Gelfand Dh, Stoffel S et al.: Primer-directed enzymatic amplification if DNA with a thermostable DNA polymerase. Science 239: 487-491, 1988
13. Akoury DA, Seo JJ, James CD, Zaki SR: RT-PCR detection of mRNA recovered from archival glass slide smears. Mod Pathol 6: 195-200, 1993
14. Zarbo RJ: DNA analysis of soft tissue tumors. In: Enzinger FM, Weiss SW (eds) Soft Tissue Tumors. Mosby, St. Louis, MO, 3rd edition: 119-138, 1995
15. Kissane JM, Askin FB, Nesbit M, Vietti T, Burgert EO Jr, Cangir A, Gehan EA, Perez CA, Pritchard DJ, Tefft M: Sarcomas of bone in childhood. Pathologic aspects. In: Glicksmann A, Tefft M (eds) Bone and soft tissue sarcoma. J Natl Cancer Inst Monograph 56: 29-41, 1981
16. Arabros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M: MIC2 is a specific marker for Ewing's sarcoma and peripheral neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67: 1886-1893, 1991
17. Kurtin PJ, Pinkus GS: Leukocyte common antigen. A diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies. Correlation with immunologie studies and ultrastructural localization. Hum Pathol 16: 353-365, 1985
18. Rosai J: Intra-abdominal desmoplastic small cell tumor. In: Rosai J (ed.) Ackerman's surgical pathology. Mosby, St. Louis, MO, 8th ed: 2145-2146, 1996
19. Turc-Carel C, Aurias A, Mugneret F, Lizard S, Sidaner I, Volk C, Thiery JP, Olschwang S, Philip I, Berger MP, Philip T, Lenoir GM, Mazabraud A: Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22) (q24;q12). Cancer Genet Cytogenet 32: 229-238, 1988
20. Aurias A, Rimbaut C, Buffe D et al.: Translocation involving chromosome 22 in Ewing's sarcoma: a cytogenetic study of four fresh tumors. Cancer Genet Cytogenet 12: 21-29, 1984
21. Zucman J, Delettre O, Desmaze C, Plougastel B, Joubert I, Melot T, Peter M, DeJong P, Rouleau G, Aurias A, Thomas G: Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosom Cancer 5: 271-277, 1992
22. Burd CG, Dreyfuss G: Conserved structures and diversity of functions of RNA-binding proteins. Science 265: 615-621, 1994
23. Ohno T, Ouchida M., Lee L, Gatalica Z, Rao VN, Reddy ESP: The EWS gene, involved in Ewing family tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9: 3087-3097, 1994
24. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, DeJong P, Rouleau G, Aurias A, Thomas G: Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359: 162-165, 1992
25. Hromas R, May W, Denny C, Raskind W, Moore J, Maki RA, Beck E, Klemsz MJ: Human FLI-1 localizes to chromosome 11q24 and has aberrant transcript in neuroepithelioma. Biochem Biophys Acta 1172: 155-158, 1993
26. Prasad DD, Rao VN, Reddy ES: Structure and expression of human Fli-1 gene. Cancer Res 52: 5833-5837, 1992
27. Watson DK, Smyth FE, Thompson DM, Cheng JO, Testa JR, Papas TS, Seth A: The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of ETS transcription factors. Cell Growth Differ 3: 705-713, 1992
28. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT: Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI-1 for transformation. Proc Natl Acad Sci USA 90: 5752-5756, 1993
29. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougaste B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O: Combinatorial generation of variable fus on proteins in the Ewing family of tumors. EMBO J 12: 4481-4487, 1993
30. Plougastel B, Zucman J, Peter M, Thomas G, Delattre O: Genomic structure of the RWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics 18: 609-615, 1993
31. Dunn T, Praisman L, Hagag N, Viola MV: ERG gene is translocated in an Ewing's sarcoma cell line. Cancer Genet Cytogenet 76: 19-22, 1994
32. Giovanni M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, Emanuel BS, Evans GA: EWS-erg and EWS-Fli-1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumor with variant translocations. J Clin Invest 94: 489-496, 1994
33. Jeon I-S, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN: A variant Ewing's sarcoma translocation t(7;22) fuses the CWS gene to the ETS gene ETV1. Oncogene 10: 1229-1234, 1995
34. Mugneret F, Lizard S, Aurias S et al.: Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16). Cancer Genet Cytogenet 32: 239-245, 1988
35. Barr FG, Galili N, Holick J et al.: Rearrangement of PAX3 paired box gene in the pediatric solid tumor alveolar rhabdomyosarcoma. Nat Genet 3: 113-117, 1993
36. Galili N, Davis RJ, Fredericks WJ et al.: Fusion of a fork head domain gene to PAX in the solid tumor alveolar rhabdomyosarcoma. Nat Genet 5: 230-235, 1993
37. Shapiro DN, Sublett JE et al.: Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53: 5108-5112, 1993
38. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG: Fusion of PAX7 to FKHR by the variant t(1;13) (p36;q 4) translocation in alveolar rhabdomyosarcoma. Cancer Res 54: 2869-2872, 1994
39. Wang-Wuu S, Soukup S, Ballard E, Gotwals B, Lampkin B, Shwng WW: Chromosomal analysis of sixteen rhabdomyosarcomas. Cancer Res 48: 983-987, 1988
40. Scrable HJ, Witte D, Shimada H et al.: Molecular differential pathology of rhabdomyosarcoma. Genes Chromosom Cancer 1: 23-35, 1989
41. Thorner P, Squire J, Chilton-MacNeill S, Marrano P, Bayani J, Malkin D, Greenberg M, Lorenzana A, Zielenska M: Is the EWS/FLI-1 fusion transcript specific for Ewing's and peripheral primitive neuroectodermal tumor? A report of tour cases showing this transcript in a wider range of tumor types. Am J Pathol 148: 1125-1138, 1996
42. Gerald WL, Miller HK, Battifora H, Miettinen M, Silva EG, Rosai J: Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol 15: 499-513, 1991
43. Biegel JA, Conrad K, Brooks JJ: Translocation (11;22) (p13;q12): primary change in intra-abdominal desmoplastic small round cell tumor. Genes Chromosom Cancer 7: 119-121, 1993
44. Gerald WL, Rosai J, Ladanyi M: Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci USA 92: 1028-1032, 1995
45. Ladanyi M, Gerald W: Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54: 2837-2840, 1994
46. de Alava E, Ladanyi M, Rosai J, Gerald WL: Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay. Am J Pathol 147: 1584-1591, 1995
47. Argatoff LH, O'Connell JX, Mathers JA, Blake Gilks C, Sorensen PHB: Detection of the EWS/WT1 gene fusion by reverse transcriptase-polymerase chain reaction in the diagnosis of desmoplastic small round cell tumor. Am J Surg Pathol 20: 406-412, 1996
48. Tison V, Cerasoli S, Morigi F, Ladanyi M, Gerald WL, Rosai J: Intracranial desmoplastic small-cell tumor. Report of a case. Am J Surg Pathol 20: 112-117, 1996
49. Enzinger FM, Weiss SW: Synovial sarcoma. In: Enzinger FM, Weiss SW (eds) Soft Tissue Tumors, Mosby, St. Louis, MO, 3rd edition: 757-786, 1995
50. Dal On P, Rao U, Jani-Sait S et al.: Chromosomes in the diagnosis of soft tissue tumors. I. Synovial sarcoma. Mod Pathol 5: 357-362, 1992
51. Limon J, Mrozek K, Mandahl N et al.: Cytogenetics of synovial sarcoma: presentation often new cases and review of the literature. Genes Chromosom Cancer 3: 338-345, 1991
52. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AML, Gusterson BA, Cooper CS: Identification of novel genes, SYT and SSX, involved in t(X:18) (p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7: 502-508, 1994
53. Nagao K, Ito H, Yoshida H: Chromosomal translocation t(X;18) in human synovial sarcoma analysed by fluorescence in situ hybridization using paraffin-embedded tissue. Am J Pathol 148: 601-609, 1996
54. Iyengar V, Lineberger AS, Kerman S, Burton NA: Synovial sarcoma of the heart. Correlation with cytogenetic findings. Arch Pathol Lab Med 119: 1080-1082, 1995
55. Roberts CA, Seemayer TA, Neff JR, Alonso A, Nelson M, Bridge JA: Translocation (X;18) in primary synovial sarcoma of the lung. Cancer Genet Cytogenet 88: 49-52, 1996
56. Eneroth M, Mandahl N, Heim S et al.: Localization of the chromosomal breakpoints in the t(12;16) in liposarcoma to subbands 12q13.3 and 16p11.2. Cancer Genet Cytogenet 48: 101-107, 1990
57. Sreekantaiah C, Karakousis CP, Leong SPL et al.: Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer 69: 2484-2495, 1992
58. Turc-Carel C, Limon J, Dal Cin P et al.: Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16) (q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet 23: 291-299, 1986
59. Knight JC, Renwick PJ, Dal Cin P, Van den Berghe H, Fletcher CDM: Translocation t(12;16) (q13:p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 54: 2837-2840, 1994
60. Crozat A, Aman P, Mandahl N, Ron D: Fusion of CHOP to a novel RNA-binding protein in myxoid liposarcoma. Nature 363: 640-644, 1993
61. Rabbitts TH, Forster A, Larson R, Nathan P: Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4: 175-180, 1993
62. Enzinger FM, Shiraki M: Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol 3: 421-435, 1972
63. Barnitzke S, Van de Ven W, Bullerdiek J: Cytogenetic and molecular analysis of an aggressive angiomyxoma. Am J Pathol 147: 580-585, 1995
64. Granados R, Cibas ES, Fletcher JA: Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology. Acta Cytol 38: 711-717, 1994
65. Weintraub H, Davis R, Tapscott S et al.: The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251: 761-766, 1991
66. Scrable H, Witte D, Shimada H et al.: Molecular differential pathology in rhabdomyosarcoma. Genes Chromosom Cancer 64: 1039-1042, 1991
67. Dias P, Parham DM, Shapiro DN et al.: Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol 137: 1283-1291, 1990
68. Wesche NA, Fletcher CDM, Dias P, Houghton PJ, Parham DM: Immunohistochemistry of MyoDl in adult pleomorphic soft tissue sarcoma. Am J Surg Pathol 19: 261-269, 1995
69. Brodeur GM, Azar C, Borther M et al.: Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer 70: 1685-1694, 1992
70. Shapiro DN, Valentine MB, Rowe ST et al.: Detection of N-myc gene amplification by fluorescence in situ hybridization: diagnostic utility for neuroblastoma. Am J Pathol 142: 1339-1346, 1993
71. Stock C, Ambros IM, Mann G, Gadner H, Amann G, Ambros PF: Detection of 1p36 deletions in paraffin sections of neuroblastoma tissues. Genes Chromosom Cancer 61: 1-9, 1993
72. Look At, Hayes FA, Shuster JJ et al.: Clinical relevance of tumor cell ploidy and N-myc amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9: 581-591, 1990
73. Taylor SR, Locker J: A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblasloma. Cancer 65: 1360-1366, 1990
74. Calonje E, Fletcher CDM: Immunohistochemistry and DNA flow cytometry in soft-tissue sarcomas. Hematol Oncol Clin North America 9: 657-675, 1995
75. Alvegard TA, Berg NO, Baldetrop B, Ferno M, Killander D, Ranstam J, Rydolm A, Akerman M: Cellular DNA content and prognosis of high grade soft tissue sarcoma: the Scandinavian Sarcoma Group Experience. J Clin Pathol 8: 538-547, 1990
76. Bauer HC, Kreicbergs A, Tribukait B: DNA content prognostic in soft tissue sarcoma: 102 patients followed for 1-10 years. Acta Orthop Scan 62: 187-194, 1991
77. El-Naggar AK, Ordonez NG, Sara A et al.: Clear cell sarcomas and metastatic soft tissue melanomas. Cancer 67: 2173-2179, 1991
78. Shapiro DN, Parham DM, Douglass EC, Ashmun R, Webber BL, Newton WA Jr, Hancock ML, Maurer HM, Look AT: Relationship of tumor cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 9: 159-166, 1991
79. Jaffe R, Santamaria M, Yunis EJ et al.: The neuroectodermal tumor of bone. Am J Surg Pathol 8: 885-898, 1984
80. Juergens H, Bier V, Harms D et al.: Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer 61: 349-357, 1988
81. Dehner LP: Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 17: 1-13, 1993
82. West DC, Rosenberg A, Sklar J, Aster JC: RT-PCR analysis of small-cell osteosarcoma for the t(11;22) (q24;q12) chromosomal translocation. Proc Annu Meet Assoc Cancer Res 35: A3452, 1994
83. Enzinger FM: Clear cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer 18: 1163-1174, 1968
84. Bridge JA, Seekantaiah C, Neff R et al.: Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts. Cancer Genet Cytogenet 52: 101-106, 1991
85. Peulve P, Michot C, Vannier J-P, Tron P, Hemet J: Clear cell sarcoma with t(12;22) (q13-14;q12). Genes Chromosom Cancer 3: 400-402, 1991
86. Stenman G, Kindblom L-G, Angervall L: Reciprocal translocation t(12;22) (q13;q12) in clear cell sarcoma of tendons and aponeuroses. Genes Chromosom Cancer 4: 122-127, 1992
87. Zucman J, Delattre O, Desmaze C., Epstein A, Stenman G, Speleman F, Fletcher CDM, Aurias A, Thomas G: EWS and ATF-1 gene fusion induced by t(11;22) translocation in malignant melanoma of soft parts. Nat Genet 4: 341-345, 1993
88. Trent J: Cytogenetics of malignant melanoma. Cancer Metastasis Rev 10: 103-113, 1991
89. Fletcher CDM, Akerman M, Dal Cin P et al.: Correlation between clinicopathological features and karyotype in lipomatous tumors. Am J Pathol 148: 623-630, 1996
90. Heim S, Nilbert M, Vanni R, Floderus U-M, Mandahl N, Liedgren S., Lecca U, Mitelman F: A specific translocation t(12;14) (q14-q15;q23-q24), characterizes a subgroup of unterine leiomyomas. Cancer Genet Cytogenet 32: 13-17, 1988
91. Turc-Carel C, Dal Cin P, Boghosian J, Terk-Zakarian J, Sandberg AA: Consistent breakpoints in region 14q22-q24 in uterine leiomyoma. Cancer Genet Cytogenet 32: 25-31, 1988
92. Heim S, Mandahl N, Kristofersson U, Mitelman F, Rooser B, Rydholm A, Willen H: Reciprocal translocation t(3;12) (q27;q13) in lipoma. Cancer Genet Cytogenet 23: 301-304, 1986
93. Turc-Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA: Cytogenetic studies of adipose tumors. I. A berign liponia with reciprocal translocation t(3;12) (q28;q14). Cancer Genet Cytogenet 23: 283-289, 1986
94. Fletcher JA, Longtine J, Wallace K, Mentzer SJ, Sugarbaker DJ: Cytogenetic and histologic findings in 17 pulmonary chondroid hamartomas: evidence for a pathogenetic relationship with lipomas and leiomyomas. Genes Chromosom Cancer 12: 220-223, 1995
95. Mark J, Dahlenfors R, Ekedahl C, Stenman G: The mixed salivary gland tumor: a normally benign human cytoplasm frequently showing specific chromosomal abnormalities. Cancer Genet Cytogenet 2: 231-241, 1980
96. Ashar HR, Schoenber Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz, Morton CC, Chada K: Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82: 57-65, 1995
97. Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Barnitzke S, Van de Ven W, Bullerdiek J: Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 55: 6038-6039, 1995
98. Emory TS, Scheithauer BW, Hirose T, Wood M, Onofrio BM, Jenkins RB: Intraneural perineurioma. A clonal neoplasm associated with abnormalities of chromosome 22. Am J Clin Pathol 103: 696-704, 1995
99. Flelcher CDM: Inflammatory pseudotumor. In: Fletcher CDM (ed.) Diagnostic Hislopathology of Tumors, Churchill Livingstone: 1084, 1995
100. Treissman SP, Gillis DA, Lee CL, Giacomantonio M, Resch L: Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor. Cancer 73: 1433-1437, 1994
101. Aterman K, Fraser GM, Lea RH: Disseminated peritoneal leiomyomatosis. Virchow Arch (Pathol Anat) 374: 13-26, 1977
102. Quade BJ: Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions. Curr Opin Obstet Gynecol 7: 35-42, 1995
103. Etranger FM, Weiss SW: Fibromatoses. In: Enzinger FM, Weiss SW (eds) Soft Tissue Tumors, Mosby, St. Louis, MO, 3rd edition: 201-229, 1995
104. Dal Cin P, Sciot R, Aly MS, Delabie J, Stas M, De Wever I, Van Damme B, Van den Berghe H: Some desmoid tumors are characterized by trisomy 8. Genes Chromosom Cancer 10: 131-135, 1994
105. Fletcher JA, Nacem R, Xiao S, Corson JM: Chromosome aberrations in desmoid tumors. Trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet 79: 139-143, 1995
106. Bridge JA, Sreekantaiah C, Mouron B, Neff JR, Sandberg AA, Wolman SR: Clonal chromosome aberrations in desmoid tumors: implications for histogenesis. Cancer 69: 430-436, 1992
107. Jaffe HL, Lichtenstein L, Sutro CJ: Pigmented villonodular synovitis, bursitis and tenosynovitis: a discussion of the synovial and bursal equivalents of the tenosynovial lesion commonly denoted as xanthoma, xanthogranuloma, giant cell tumor or myeloplaxoma of the tendon sheath, with some consideration of tendon sheath lesion itself. Arch Palhol 31: 731-765, 1941
108. Fletcher JA, Henkle C, Atkins L, Rosenberg AE, Morton CC: Trisomy 5 and trisomy 7 are nonrandom aberrations in pigmented villonodular synovitis: confirmation of trisomy 7 in uncultured cells. Genes Chromosomes Cancer 4: 264-266, 1992
109. Gonzalez-Campora R, Salas Herrero E, Otal-Salaverri C, Villar-Rodriguez JL, San Martin Diez V, Hevia Vazquez A, Galera Davidson H: Diffuse tenosynovial giant cell tumor of soft tissues. Report of a case with cytologie and cytogenetic findings. Acta Cytol 39: 770-776, 1995
110. Choong PF, Willen H, Nilbert M, Mertens F, Mandahl N, Carlen B, Rydholm A: Pigmented villonodular synovitis. Monoclonality and metastasis - a case for neoplastic origin? Acat Orthop Scand 66: 64-68, 1995
111. Vogelstein B, Fearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, Riggs AD, Orkin SH: Clonal analysis using recombinant DNA probes from the X chromosome. Cancer Res 68: 4806-4813, 1987
112. Mashal RD, Schoenberg Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morion C, Sklar J: Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cylogenetic aberration in the development of leiomyomata. Genes Chromosom Cancer 7: 1-6, 1994
113. Taylor HB, Helwig EB: Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 15: 717-725, 1962
114. Fletcher CDM: Giant cell fibroblasloma of soft tissue: a clinicopathological and immunohistochemical study. Histopathology 13: 499-508, 1988
115. Beham A, Fletcher CDM: Dermatofibrosarcoma protuberans with areas resembling giant cell fibroblastoma: report of two cases. Histopathology 17: 165-167, 1990
116. Alguacil-Garcia A: Giant cell fibroblastoma recurring as dermatofibrosarcoma protuberans. Am J Surg Pathol 15: 798-801, 1991
117. Coyne J, Kalton SM, Craig RDP: Dermatofibrosarcoma protuberans recurring as a giant cell fibroblastoma. Histopathology 21: 184-187, 1992
118. Pedeutour F, Coindre JM, Sozzi G, Nicolo G, Leroux A, Toma S, Miozzo M, Bouchot C, Hecht F, Ayraud N et al.: Supernumerary ring chromosomes containing chromosome 17 sequences: a specific feature of dermatofibrosarcoma protuberans? Cancer Genet Cytogenet 76: 1-9, 1994
119. Naeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA: Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol 147: 1553-1558, 1995
120. Craver RD, Correa H, Kao YS, Van Brunt T, Golladay ES: Aggressive giant cell fibroblastoma with a balanced 17;22 translocation. Cancer Genet Cytogenet 80: 20-22, 1995
121. Crum CP, Ikenberg H, Richart RM, Gissman L: Human papilloma virus type 16 and early cervical neoplasia. N Engl J Med 310: 880-883, 1984
122. Chadwick EG, Conner EJ, Hanson CG, Joshi VV, Abu-Farsakh H, Yogev R, McSherry G, McClain K, Murphy SB: Tumors of smooth-muscle origin in HIV-infected children. JAMA 263: 3182-3184, 1990
123. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 332: 1181-1185, 1995
124. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO'D, Weiss RA, O'Leary JJ: Kaposi's sarcoma associated herpes virus infects endothelial and spindle cells. Nat Med 1: 1274-1278, 1995
125. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila D, dePaepe AT, Tryggvason K, Reeders ST: Detection of paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 261: 1167-1169, 1993
126. Hoolingsworlh RE Jr, Chen PL, Lee WH: Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein. Curr Opin Cell Biol 5: 194-200, 1993
127. Reissmann PT, Simon MA, Lee WH, Slamon DJ: Studies of the retinoblastoma gene in human sarcomas. Oncogene 4: 839-843, 1989
128. Levine AJ: The p53 tumor-suppressor gene. N Engl J Med 326: 1350-1352, 1992
129. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B: p53 mutation and mdm2 amplification in human soft tissue sarcomas. Cancer Res 53: 2231-2334, 1993
130. Latres E, Drobnjak M, Pollack D, Oliva MR. Ramos M, Karpeh M, Woodruff JM, Cordon-Cardo C: Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas. Am J Pathol 145: 345-355, 1994
131. Dei Tos AP, Doglioni C, Laurino L, Barbareschi M, Fletcher CD: p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopalhology 22: 45-50, 1993
132. Dei Tos AP, Maestro R, Doglioni C, Gasparotto D, Boiocchi M, Laurino L, Fletcher CDM: Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 145: 11-17, 1994
133. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992
134. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW. Vogelstein B: Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362: 857-866, 1993
135. Cordon-Cardo CC, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794-799, 1994
136. Legius E, Marchuk DA, Collins FS, Glover TW: Somatic-deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports the tumour suppressor hypothesis. Nat Genet 3: 122-126, 1993
137. Gutmann DH, Wood DL, Collins FS: Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 88: 9658-9662, 1991
138. Li Y, Bollag G, Clark R, Stevens J, Conroy L. Fults D, Ward K, Friedman E, Samowitz W, Robertson M et al.: Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69: 275-281, 1992